Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.2606 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)NC1=NC2=CC(=CC=C2N1)C(=O)C3CC3
InChI
InChIKey=OXLKOMYHDYVIDM-UHFFFAOYSA-N
InChI=1S/C13H13N3O3/c1-19-13(18)16-12-14-9-5-4-8(6-10(9)15-12)11(17)7-2-3-7/h4-7H,2-3H2,1H3,(H2,14,15,16,18)
| Molecular Formula | C13H13N3O3 |
| Molecular Weight | 259.2606 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
1200 mg single, oral Highest studied dose |
unhealthy, UNKNOWN Health Status: unhealthy Age Group: UNKNOWN Sex: unknown Food Status: UNKNOWN Sources: |
Other AEs: Vomiting, Diarrhoea... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Diarrhoea | 1200 mg single, oral Highest studied dose |
unhealthy, UNKNOWN Health Status: unhealthy Age Group: UNKNOWN Sex: unknown Food Status: UNKNOWN Sources: |
|
| Vomiting | 1200 mg single, oral Highest studied dose |
unhealthy, UNKNOWN Health Status: unhealthy Age Group: UNKNOWN Sex: unknown Food Status: UNKNOWN Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| In vitro susceptibilities of the AIDS-associated microsporidian Encephalitozoon intestinalis to albendazole, its sulfoxide metabolite, and 12 additional benzimidazole derivatives. | 1997-12 |
|
| Comparative trial on the therapeutic effectiveness of the new anthelmintic drug: ciclobendazole. | 1978-12 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/493246
Oxyuriasis treatment: 50 children were treated twice with 100 mg of cyclobendazole each, at a weekly interval
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/7811023
Cyclobendazole inhibited G. lamblia growth with IC50 0.047 ug/ml.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:31 GMT 2025
by
admin
on
Mon Mar 31 18:24:31 GMT 2025
|
| Record UNII |
JF3KQ40J31
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C250
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
||
|
WHO-ATC |
P02CA04
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
31431-43-3
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
CICLOBENDAZOLE
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
DB13465
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
335307
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
JF3KQ40J31
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
m3975
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID9057713
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
3120
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
SUB06240MIG
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
250-637-5
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
35803
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
100000081906
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
C78041
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
3570
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL1788401
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY | |||
|
C014415
Created by
admin on Mon Mar 31 18:24:31 GMT 2025 , Edited by admin on Mon Mar 31 18:24:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |